Baxter International Inc (BAX) concluded trading on Wednesday at a closing price of $33.02, with 3.5 million shares of worth about $115.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -0.51% during that period and on December 04, 2024 the price saw a loss of about -0.33%. Currently the company’s common shares owned by public are about 510.46M shares, out of which, 506.56M shares are available for trading.
Stock saw a price change of 0.46% in past 5 days and over the past one month there was a price change of -7.77%. Year-to-date (YTD), BAX shares are showing a performance of -14.59% which decreased to -10.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $31.60 but also hit the highest price of $44.01 during that period. The average intraday trading volume for Baxter International Inc shares is 3.85 million. The stock is currently trading -1.21% below its 20-day simple moving average (SMA20), while that difference is down -6.64% for SMA50 and it goes to -11.09% lower than SMA200.
Baxter International Inc (NYSE: BAX) currently have 510.46M outstanding shares and institutions hold larger chunk of about 93.70% of that.
The stock has a current market capitalization of $16.86B and its 3Y-monthly beta is at 0.57. PE ratio of stock for trailing 12 months is 144.00, while it has posted earnings per share of $0.23 in the same period. It has Quick Ratio of 1.09 while making debt-to-equity ratio of 1.68. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BAX, volatility over the week remained 1.53% while standing at 2.59% over the month.
Stock’s fiscal year EPS is expected to drop by -29.65% while it is estimated to increase by 40.19% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on July 15, 2024 offering an Underweight rating for the stock and assigned a target price range of between $39 and $30 to it. Coverage by Goldman stated Baxter International Inc (BAX) stock as a Neutral in their note to investors on May 30, 2024, suggesting a price target of $36 for the stock. On May 10, 2024, TD Cowen Downgrade their recommendations, while on May 30, 2023, Morgan Stanley Resumed their ratings for the stock with a price target of $45. Stock get a Neutral rating from UBS on March 29, 2023.
